Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

Total article views   Abstract views HTML views PDF downloads Totals
5,452 Dovepress* 3,871 918+ 744 4,789
PubMed Central* 0 663 155 663
Totals 3,871 1,581 899 5,452
*Since 1 June 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 6 8

View citations on PubMed Central and Google Scholar